arsenic trioxide has been researched along with Carcinoma, Lewis Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calderon, PB; Dauguet, N; Diepart, C; Feron, O; Gallez, B; Grégoire, V; Jordan, BF; Karroum, O; Leveque, P; Magat, J; Stockis, J; Verrax, J | 1 |
1 other study(ies) available for arsenic trioxide and Carcinoma, Lewis Lung
Article | Year |
---|---|
Arsenic trioxide treatment decreases the oxygen consumption rate of tumor cells and radiosensitizes solid tumors.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Lewis Lung; Combined Modality Therapy; Disease Models, Animal; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Oxides; Oxygen Consumption; Radiation-Sensitizing Agents | 2012 |